Eliem Therapeutics Property, Plant, and Equipment 2021-2024 | CLYM

Eliem Therapeutics property, plant, and equipment from 2021 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Eliem Therapeutics Annual Property, Plant, and Equipment
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
Eliem Therapeutics Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.342B $0.000B
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
Stock Name Country Market Cap PE Ratio
Chesapeake Energy (EXE) United States $11.186B 28.69
Hammerson (HMSND) United Kingdom $2.121B 0.00
American Software (LGTY) United States $0.388B 29.97
Learn CW Investment (INV) United States $0.204B 0.00
Nicholas Financial (OMCC) United States $0.079B 0.00
ExcelFin Acquisition (BDMD) $0.033B 0.00
Caravelle Group (HTCO) Singapore $0.024B 0.00
Recruiter (NIXX) United States $0.007B 0.00